top of page

Psychological Encyclopedia

Charcot, Hysteria, and the Prehistory of Modern Neurosis

Sep 30
20 min read

Author: Ukrainian Psychological Hub · Published: September 30, 2026 · Editorial Policy


Jean-Martin Charcot did not create a modern diagnosis called neurosis, and his hysteria is not a synonym for any single disorder used today. His importance lies elsewhere. At the Salpêtrière in late nineteenth-century Paris, Charcot treated hysteria as a legitimate object of neurological investigation, described recurring motor, sensory, seizure-like, and dissociative phenomena, used hypnosis as an experimental tool, and increasingly explored trauma and psychological mechanisms. That work helped move part of the older territory of the neuroses from a purely somatic language toward the psychology that Pierre Janet and Sigmund Freud would develop in different directions. Historical reviews of Charcot’s work describe this transition as gradual rather than a single theoretical conversion.


For a modern reader, the safest way to understand Charcot’s hysteria is as a historically specific nineteenth-century construct. Some of its neurological-like presentations overlap with what contemporary clinicians may diagnose as functional neurological disorder, while some dissociative phenomena belong to other modern categories. The overlap is genealogical and phenomenological, not a one-to-one diagnostic equivalence. DSM-5-TR does not diagnose “hysteria” or “neurosis,” and ICD-11 uses its own contemporary categories, including Dissociative Neurological Symptom Disorder. The World Health Organization’s 2024 ICD-11 CDDR provides the current ICD framework.


This article therefore follows Charcot historically: what he meant by hysteria, why the Salpêtrière mattered, how hypnosis and trauma entered his model, why his demonstrations became controversial, how his ideas changed late in his career, how Freud and Janet inherited different parts of the problem, and what modern classification retains or rejects. For the broader umbrella term, see Neurosis: What It Means Today, Symptoms, History, and Modern Diagnoses; for the later formal psychiatric category, see Hysterical Neurosis: Historical Meaning, Dissociation, and Functional Neurological Symptoms.


Who Was Jean-Martin Charcot, and Why Does Hysteria Matter in the History of Neurosis?


Jean-Martin Charcot (1825–1893) was a French neurologist whose career at the Salpêtrière helped establish clinical neurology as a distinct discipline. His best-known neurological work extended far beyond hysteria, but hysteria became one of the most consequential problems of his later career because it challenged the method on which nineteenth-century neurology had built much of its authority: correlate a stable clinical syndrome with a demonstrable anatomical lesion.


In diseases such as multiple sclerosis, Parkinsonian syndromes, or focal neurological injuries, the anatomo-clinical method could connect signs observed at the bedside with pathological changes identified after death. Hysteria repeatedly frustrated that logic. Patients could present with paralysis, contracture, anesthesia, abnormal movements, visual disturbance, aphonia, convulsive attacks, or other dramatic neurological-like symptoms, yet the expected structural lesion was absent. Charcot’s response was not to dismiss the symptoms as imaginary. He attempted to give them a medical, neurological status. Goetz’s historical review emphasizes that Charcot sharply distinguished hysteria from conscious simulation even while recognizing that the two could be difficult to separate.


That move matters for the history of neurosis because the nineteenth-century word “neurosis” was much broader than the later psychoanalytic or mid-twentieth-century psychiatric concept. It referred to disorders of nervous function whose pathology was uncertain or not reducible to a visible lesion. Hysteria became one of the great testing grounds for that category. Charcot’s work sits between an older neurological nosology and the later psychological theories of neurosis. It is therefore a prehistory of modern neurosis in the sense of intellectual lineage, not because Charcot invented the term or because his hysteria directly became a current diagnosis.


Hysteria Before Charcot: A Category Already in Motion


Hysteria had a very long history before Charcot. The term carried accumulated associations with the uterus, sexuality, emotionality, nervous weakness, bodily symptoms, and social ideas about femininity. By the nineteenth century, however, physicians had already begun to detach hysteria from a narrowly gynecological explanation and to interpret it as a disorder of the nervous system. Charcot inherited a category that was already changing; he did not simply replace an ancient “wandering womb” idea with neurology in one decisive step. Gomes and Engelhardt’s historical review traces this longer shift from gynecological to nervous-system explanations.


This context is important because simplified histories often make Charcot appear either as the man who “discovered” hysteria or as the man who invented a false disease through theatrical demonstrations. Both stories compress a more complicated record. There were patients with disabling neurological-like and dissociative symptoms before Charcot, and there were competing medical interpretations of those symptoms. What Charcot’s school did was reorganize, standardize, photograph, demonstrate, and theorize a particular clinical picture with unusual institutional power.


The Salpêtrière: Hospital, Neurological School, and Stage of Observation


The Salpêtrière was not merely a backdrop. Its large patient population, teaching structure, wards, laboratories, photographic practices, and public clinical lessons made it possible to observe recurrent patterns on a scale unavailable to most private physicians. Charcot and his collaborators could compare patients, follow them over time, draw and photograph physical signs, and turn individual cases into teaching material.


This setting also created a problem that later historians have taken seriously: observation was never socially neutral. Patients learned the routines of the institution; physicians selected which cases were exemplary; assistants repeated examinations; photographers and artists fixed certain postures as canonical; audiences expected recognizable performances. The famous image of Charcot lecturing while a woman diagnosed with hysteria collapses into an assistant’s arms has become an icon precisely because the clinic was also a spectacle.


The existence of spectacle does not establish that symptoms were consciously fabricated. It does mean that the production of medical knowledge occurred inside a relationship among patients, doctors, expectations, technologies of display, and institutional authority. Some historians have argued that the Salpêtrière environment amplified or shaped the form in which hysterical attacks appeared. Others emphasize Charcot’s genuine effort to distinguish involuntary symptoms from simulation and the enduring clinical relevance of some observations. The historical record supports debate rather than a single caricature. The 2025 historical analysis by Toby Gelfand is especially useful for understanding how Charcot’s thinking evolved within this institutional setting.


What Did Charcot Mean by Hysteria?


Charcot’s “hysteria” was not a single symptom. It was a broad clinical disorder whose manifestations could imitate many neurological diseases without following the anatomical pattern expected from a destructive lesion. His patients could show sensory loss, pain, visual changes, motor weakness, paralysis, contractures, tremor, abnormal movements, gait disturbance, aphonia, seizure-like attacks, amnesia, suggestibility, and other phenomena. The exact boundaries of the category changed across his career.


His published lectures also used language such as hystero-epilepsy for dramatic attacks that resembled epilepsy but were regarded as hysterical. That historical term must not be read as a modern hybrid diagnosis of epilepsy plus a psychiatric disorder. Contemporary neurology differentiates epileptic seizures from functional or dissociative seizures using modern clinical semiology, video-EEG when appropriate, and other evidence. The nineteenth-century label belonged to a different diagnostic system.


Charcot’s own Lectures on the Diseases of the Nervous System show how hysteria and hystero-epilepsy were treated as major clinical topics at the Salpêtrière. The text is valuable as a primary source because it reveals the categories, signs, and assumptions of Charcot’s period rather than translating them into modern terminology.


The “Stigmata” and the Search for Stable Clinical Signs


Charcot sought signs that would give hysteria the same clinical solidity as other neurological diseases. He described relatively persistent features—historically called stigmata—such as characteristic patterns of anesthesia, sensory disturbance, visual-field changes, or motor abnormalities. The project was classificatory: if hysteria had reproducible signs, it could be studied as a disease rather than dismissed as caprice.


Modern clinicians should not reuse those signs as diagnostic criteria. Nineteenth-century neurological examination, concepts of localization, patient populations, and expectations differed substantially from contemporary practice. The historical importance lies in the attempt to make involuntary functional symptoms observable and medically legitimate.


Grande Hystérie and the Four-Phase Attack


One of the Salpêtrière school’s most famous constructions was the staged attack of grande hystérie. Charcot and Paul Richer described dramatic attacks progressing through recognizable phases, including epileptoid movements, contortions and large movements, expressive postures, and a delirious terminal phase. The model became visually powerful because drawings and photographs could display each stage as if it were a natural sequence.


The sequence should be treated as a school-specific historical description, not as a timeless biological pattern. Later clinicians did not find that all patients with functional or dissociative seizures follow Charcot’s canonical stages. The very regularity of the Salpêtrière attacks became part of the criticism directed at the school, especially when symptoms changed after Charcot’s death and when other hospitals reported different forms.


Hysteria in Men: A Major Break with a Gendered Tradition


Charcot’s attention to male hysteria was historically significant. A diagnosis culturally tied to femininity and reproductive anatomy became, in his work, a nervous disorder that could occur in men. His male cases often appeared in the context of accidents, occupational injuries, railway trauma, or other physical shocks. This undermined any simple theory that hysteria was intrinsically a disease of the female reproductive system.


The shift did not remove gender bias from the history of hysteria, but it changed the explanatory field. If men could develop hysterical paralysis, anesthesia, or attacks after injury, the cause had to be conceptualized in terms broader than the uterus. Charcot increasingly used hereditary vulnerability, nervous-system function, trauma, and psychological shock to explain why symptoms emerged.


Trauma, Traumatic Hysteria, and the Agent Provocateur


Between the late 1870s and his death, Charcot published cases that he described as traumatic hysteria. His model commonly combined a constitutional or hereditary predisposition with an external trigger—an agent provocateur. The trigger might be bodily injury, fright, or an accident. Over time, the psychological impact of the event became more prominent in his explanations.


Historian Mark Micale identified more than twenty Charcot case histories concerned with traumatic hysteria and noted an increasing emphasis in the 1880s on psychical shock. Micale’s historical analysis is useful because it shows that Charcot’s trauma concept developed inside a nineteenth-century framework of heredity and degeneration rather than anticipating modern trauma diagnosis intact.


This distinction prevents a common retrospective error. Charcot’s traumatic hysteria is not post-traumatic stress disorder. Some patients described by nineteenth-century clinicians might, if assessed today, meet criteria for a trauma-related disorder, FND, a dissociative disorder, a neurological condition, or another diagnosis; others cannot be classified confidently from historical records. Similar causal language across centuries does not create diagnostic identity.


The “Dynamic Lesion”: When Symptoms Were Real but Anatomy Was Silent


One of Charcot’s most influential ideas was the “dynamic” or “functional” lesion. The phrase expressed a dilemma: patients had genuine symptoms with patterned effects on movement or sensation, yet postmortem anatomy did not reveal a destructive lesion that could account for them. Charcot proposed an alteration of nervous function rather than a gross structural injury.


Modern writers sometimes present the dynamic lesion as a direct nineteenth-century discovery of today’s functional brain-network models. The resemblance is intellectually striking but historically incomplete. Charcot did not possess electrophysiology, contemporary neuroimaging, predictive-processing models, network neuroscience, or current diagnostic criteria. His “dynamic lesion” belonged to a physiological vocabulary shaped by the knowledge and assumptions of his era.


Still, the problem he identified remains recognizable: how can severe neurological symptoms occur when the expected structural pathology is absent? Contemporary FND research addresses that question with different methods and models. A 2024 review tracing FND from Charcot to current practice emphasizes that diagnosis today rests on positive clinical signs and modern neurological assessment rather than on the mere absence of a lesion.


Hypnosis: Charcot’s Experimental Model of Hysteria


Hypnosis became central to Charcot’s work because it seemed to offer an experimental way to reproduce, alter, or relieve phenomena resembling hysterical symptoms. If suggestion under hypnosis could produce paralysis, anesthesia, contracture, or other changes without structural damage, then a powerful idea could apparently modify bodily function. For Charcot, this offered a bridge between physiology and psychology.


His school described stages of hypnosis and often treated susceptibility to these states as closely linked to hysteria. That claim was challenged by the Nancy school, especially Hippolyte Bernheim, who argued that suggestion and hypnotizability were not pathological properties unique to hysterical patients. The dispute mattered because it asked whether hypnosis revealed the natural physiology of a disease or whether the experiment itself helped shape the response.


Modern hypnosis research does not treat Charcot’s staged hypnotic model as a diagnostic test for FND or dissociative disorders. However, cognitive neuroscience has continued to compare hypnotic suggestion, dissociation, agency, and functional neurological symptoms. Bell, Oakley, Halligan, and Deeley’s review found intriguing parallels while also stressing major limits in the evidence. Historical continuity therefore exists at the level of research questions, not a preserved diagnostic doctrine.


Were the Salpêtrière Patients Performing for Charcot?


This question is often framed too crudely. “Performance” can mean conscious deception, socially shaped behavior, learned symptom expression, responses to suggestion, or the inevitable fact that clinical observation changes what is observed. These are not equivalent.


Charcot explicitly rejected the idea that hysteria was simply malingering, and his work helped legitimate patients whose symptoms lacked an anatomical explanation. At the same time, repeated demonstrations, hypnosis, institutional expectations, photography, and a small number of celebrated patients created conditions in which suggestion and learning could influence symptom form. Historical criticism of the Salpêtrière therefore does not justify dismissing all patients as actors.


A useful modern lesson follows. Functional neurological symptoms are not defined as intentional fabrication. Contemporary diagnostic work distinguishes FND from factitious disorder and malingering, and modern reviews emphasize positive clinical features rather than moral judgments about whether a person is “really” ill. Current FND diagnostic reviews explicitly describe an inclusionary neurological approach.


Charcot’s Theory Changed: From Neurological Hysteria Toward Psychology


Charcot’s position was not static. Earlier phases of his work emphasized a neurological disease model, hereditary predisposition, and dynamic cerebral dysfunction. Later teaching increasingly acknowledged psychological mechanisms, emotional factors, suggestibility, ideas, and trauma. This gradual change helps explain why different summaries of Charcot can sound contradictory: they may be describing different moments in a twenty-year intellectual trajectory.


The tension is visible in his late Tuesday lessons. Francesco Brigo’s analysis of Charcot’s 1888 teaching shows that handwritten records could formulate hysteria in strongly psychological terms while edited printed versions softened that emphasis. The discrepancy is historically revealing. Charcot was moving toward a psychological account without abandoning the physiological language that had made hysteria a neurological object.


Toby Gelfand’s study of a previously unpublished late case likewise argues that Charcot’s final work explored dreams, suggestibility, and psychological mechanisms more fully than the conventional image of a purely neurological Charcot suggests. Gelfand’s 2025 article supports a picture of intellectual transition rather than doctrinal consistency.


Pierre Janet: Dissociation and the French Psychological Line


Pierre Janet developed one of the most important psychological inheritances of the Salpêtrière tradition. His work on automatisms, dissociation, narrowed fields of consciousness, fixed ideas, and psychological weakness offered an account of hysterical and dissociative phenomena that differed from Freud’s later theory of repression and conflict.


Janet matters because the history of hysteria is often narrated as a straight line from Charcot to Freud. That line is incomplete. Charcot’s circle generated multiple psychological programs. Walusinski and Bogousslavsky’s review describes how Charcot and Janet contributed to French models of psychopathology and to concepts of processes outside ordinary conscious control.


For modern classification, Janet’s concepts cannot simply be mapped onto today’s dissociative disorders either. They belong to a historical theory with its own architecture. Their importance is conceptual: they helped make dissociation a serious object of psychological and clinical investigation.


Freud at the Salpêtrière: What Charcot Changed


Sigmund Freud studied with Charcot in Paris in 1885–1886. The encounter was formative because Freud saw neurological-like symptoms treated as genuine even when the standard neurological lesion could not be demonstrated, and he saw hypnosis used to manipulate symptom expression. That experience widened the space in which psychological causation could be considered medically serious.


Freud did not simply adopt Charcot’s theory. He later moved away from Charcot’s hereditary emphasis and from hypnosis as his principal method, developing models centered on defense, repression, conflict, memory, sexuality, and the conversion of affect into bodily symptoms. The pathway from Charcot to psychoanalysis was therefore transformation, not inheritance by copying.


A study of Freud’s surviving French-language library found a marked concentration of works on hysteria and hypnotism from Charcot and his circle and interpreted this record as evidence of Freud’s movement from classical neuropathology toward psychology. Bogousslavsky’s analysis of Freud’s Salpêtrière library provides unusually concrete evidence of that intellectual environment.


The dedicated English Hub article Freud on Hysteria and Neurosis: Conversion, Repression, and Symptom Formation owns the full psychoanalytic intent. Here the relevant point is historical: Charcot made hysteria a problem that could no longer be contained by structural neurology alone, and Freud turned that problem into one of the starting points of psychoanalysis.


Why This Is a Prehistory of Modern Neurosis Rather Than a Modern Diagnosis


The title “prehistory of modern neurosis” describes a transition in explanatory style. The term neurosis existed before Charcot, and later psychiatric manuals and psychoanalytic schools used it in ways Charcot did not. What his hysteria research contributed was a particularly influential demonstration that severe bodily symptoms could be medically real, patterned, and involuntary even when a fixed anatomical lesion was not found.


That opened several routes. One route led toward psychodynamic theories of conversion and repression. Another led toward dissociation. Another remained within neurology and eventually contributed to the modern study of functional neurological disorders. Twentieth-century psychiatric classification later placed some of these phenomena under “hysterical neurosis,” but that was a later formal category, not Charcot’s DSM-style diagnosis.


For the historical types that were eventually organized under the neurosis umbrella, see Types of Neurosis: Historical Categories and Their Modern Equivalents. The distinction keeps three levels separate: Charcot’s nineteenth-century disease concept, twentieth-century diagnostic categories such as DSM-II hysterical neurosis, and current diagnostic systems.


What Happened to Hysteria in Modern Classification?


There is no single modern diagnosis that replaced all of hysteria. The historical category was too broad. Different parts of its territory were redistributed across functional neurological, dissociative, somatic, trauma-related, anxiety-related, neurological, and other diagnostic domains. Some historical cases cannot be translated at all because the records do not provide the information required by current criteria.


DSM-5-TR


DSM-5-TR, published by the American Psychiatric Association in 2022, does not list hysteria or neurosis as current diagnoses. Neurological-like functional symptoms are addressed under Functional Neurological Symptom Disorder (Conversion Disorder), within Somatic Symptom and Related Disorders. Contemporary diagnostic thinking no longer requires clinicians to prove a particular unconscious conflict or psychological stressor as the cause of the neurological symptom. The diagnosis is supported by positive evidence of incompatibility with recognized neurological disease patterns rather than by “nothing was found.” Espay and colleagues’ review summarizes this modern shift.


The classification change is part of a much wider reorganization that began decades earlier. The American Psychiatric Association’s DSM history describes DSM-III in 1980 as a major move toward explicit diagnostic criteria and a more descriptive system. That transition dismantled the central position previously held by the neuroses in American psychiatric classification.


ICD-11


ICD-11 organizes the territory differently. The 2024 World Health Organization Clinical Descriptions and Diagnostic Requirements includes Dissociative Neurological Symptom Disorder (6B60) within Dissociative Disorders, with presentations involving sensory, motor, seizure-like, speech, gait, cognitive, and other symptoms. WHO’s ICD-11 CDDR is the authoritative current source for this classification.


The difference between DSM-5-TR and ICD-11 demonstrates why “hysteria equals FND” is too simple. Even contemporary systems organize related phenomena differently. A historical term that once included a large and unstable territory cannot be translated by substituting one current label.


What Charcot’s Hysteria Maps Onto Today—and What It Does Not


The strongest modern continuity is with functional neurological symptoms: weakness, abnormal movement, sensory disturbance, gait disorder, speech disturbance, and seizure-like episodes that are involuntary and can be diagnosed through positive clinical features. The historical connection is real enough that modern reviews of FND routinely discuss Charcot. It is still a connection across changing concepts, methods, and diagnostic rules.


Dissociation is another line of continuity, especially through Janet and through historical states involving amnesia, altered awareness, or discontinuity in experience. Yet modern dissociative diagnoses are defined by contemporary criteria and should not be assigned retrospectively to Charcot’s patients merely because the word “dissociation” appears in later interpretations.


Trauma is a third connection. Charcot recognized that accidents and psychological shock could precipitate symptoms in vulnerable people. Modern research also finds that stress and trauma are relevant for many people with FND, but neither is universally present nor a required universal cause. Contemporary models are multifactorial, and a current diagnosis should not be reduced to the idea that the body is expressing a hidden psychological conflict.


Finally, modern neurological differential diagnosis matters in a way unavailable to Charcot. Epilepsy, movement disorders, inflammatory disease, stroke, neuropathy, migraine, sleep disorders, medication effects, and other conditions can produce symptoms that overlap superficially with historical descriptions of hysteria. Current clinicians diagnose the person in front of them, not the nineteenth-century category.


What Survived from Charcot—and What Did Not


Several of Charcot’s commitments remain historically important: symptoms can be involuntary and disabling without a gross structural lesion; functional disturbance can produce patterned neurological phenomena; trauma or emotional events can sometimes precipitate symptoms; and simulation should not be assumed simply because anatomy does not explain the presentation. Modern FND practice also values careful positive examination rather than dismissive diagnosis by exclusion.


Other parts of Charcot’s framework did not survive. Hereditary degeneration theory is not the accepted explanatory foundation of FND. The Salpêtrière’s canonical staged grande hystérie is not a modern diagnostic sequence. Hypnotizability is not a diagnostic hallmark. Ovarian theories and other period-specific bodily assumptions have no place in current classification. The notion that every functional symptom can be traced to one hidden psychological trauma or conflict is also unsupported as a universal rule.


The most productive historical reading therefore neither canonizes nor mocks Charcot. His work contains observations that opened important research programs and assumptions that later medicine discarded. The history is valuable precisely because it shows how clinical categories are made, revised, split, and sometimes abandoned.


Charcot, Hysteria, and Modern Functional Neurological Disorder


Functional neurological disorder is the modern clinical area most likely to be invoked when Charcot’s hysteria is discussed. The overlap is understandable: both concern neurological symptoms that cannot be explained in the same way as a structural neurological lesion, and both raise questions about agency, attention, expectation, emotion, learning, trauma, and brain function.


The modern field, however, is not Charcot’s model with new terminology. Current diagnosis uses positive signs such as inconsistency or incongruity with recognized neurological patterns in appropriate contexts; it does not require hypnosis, dramatic attacks, a hereditary “neuropathic constitution,” or proof of psychogenesis. Modern research examines distributed neural networks, predictive processes, attention, agency, interoception, learning, and biopsychosocial factors. Evidence is still developing, and no single mechanism explains all FND presentations.


The clinical implication is practical: a person with paralysis, tremor, non-epileptic seizures, sensory loss, or another neurological symptom should not self-translate the symptom into “hysteria.” New or severe neurological symptoms need contemporary medical assessment. Historical labels are tools for interpreting texts and ideas, not shortcuts around differential diagnosis.


Common Misconceptions About Charcot and Hysteria


“Charcot invented hysteria.”


Hysteria existed as a medical category long before Charcot. His school transformed its neurological and psychological meaning, standardized certain presentations, and gave the diagnosis unprecedented visibility.


“Charcot thought hysteria affected only women.”


Charcot explicitly studied hysteria in men, especially in relation to accidents and trauma. Male cases were important because they weakened reproductive explanations of the disorder.


“Hysterical patients were simply pretending.”


Charcot treated hysteria as genuine illness and distinguished it from conscious simulation. The later debate about suggestion and performance concerns how symptoms may be shaped by context, not a blanket conclusion that patients were faking.


“Hypnosis proved Charcot’s theory.”


Hypnosis was an experimental tool and a source of evidence within Charcot’s framework, but its interpretation was contested at the time. The Nancy school challenged the claim that hypnotic states were specific to hysteria.


“Charcot’s hysteria is the old name for FND.”


Some neurological-like manifestations have a strong historical relationship to FND, but Charcot’s category was broader and theory-laden. Modern FND has contemporary criteria and cannot be equated with the whole nineteenth-century construct.


“Freud simply inherited Charcot’s theory.”


Charcot influenced Freud profoundly, but Freud reformulated the problem through his own theories of defense, repression, conflict, conversion, and symptom meaning. The intellectual relationship is one of transformation.


How to Read a Historical Diagnosis of Hysteria Today


When “hysteria,” “hystero-epilepsy,” “traumatic hysteria,” or a related term appears in an old case record, first identify the date, country, author, and theoretical school. The same word could mean different things in Charcot’s neurology, Janet’s psychology, Freud’s psychoanalysis, early twentieth-century psychiatry, or DSM-era American classification.


Second, reconstruct the actual phenomena rather than translating the label. Was the record describing paralysis, anesthesia, convulsive episodes, amnesia, fugue, pain, panic, trauma symptoms, or a personality judgment? Modern classification depends on the specific presentation.


Third, separate historical explanation from current evidence. If Charcot attributed a symptom to hereditary degeneration plus trauma, that is what his theory proposed. It does not establish the cause of a modern patient’s symptoms. If Freud later invoked repression or conversion, that is a psychoanalytic mechanism, not a DSM-5-TR diagnostic requirement.


Fourth, preserve diagnostic uncertainty. Retrospective diagnosis is especially weak when historical notes lack neurological examination, duration, impairment, comorbidity, substance or medication information, imaging, electrophysiology, and the positive signs used today. A historically accurate answer often ends with several possible modern categories rather than one supposed equivalent.


Clinical and Treatment Implications for a Modern Reader


Charcot’s history is clinically relevant because old stereotypes still affect patients with functional neurological symptoms. The idea that symptoms are “not organic” can be misheard as “not real,” while the word hysteria can carry gendered, dismissive, or pejorative meanings. Contemporary care rejects that shortcut.


Modern FND assessment is based on a positive diagnosis when appropriate, careful neurological differential diagnosis, clear explanation, and individualized treatment. Depending on the presentation, care may involve neurology, physiotherapy or occupational therapy adapted for FND, psychological treatment, treatment of comorbid conditions, and other rehabilitation. Current reviews of FND diagnosis and treatment emphasize multidisciplinary care and positive diagnostic signs.


Nothing in Charcot’s history can diagnose a present-day reader. Sudden weakness, loss of speech, new seizure-like events, severe sensory loss, or other acute neurological symptoms can have urgent medical causes and should be evaluated on current clinical grounds. Historical knowledge explains the lineage of ideas; it does not replace medical assessment.


Why Charcot Still Matters


Charcot still matters because he stands at a fault line in the history of mind and medicine. Hysteria forced neurologists to confront symptoms that were visible, disabling, and bodily but resistant to the lesion-based explanations available at the time. His school responded by expanding observation, experimenting with hypnosis, theorizing functional disturbance, and eventually moving toward psychological explanation.


That transition created problems that remain recognizable: how expectation changes perception and movement; how trauma can affect bodily function without providing a universal explanation; how clinicians distinguish involuntary symptoms from conscious fabrication; how a diagnosis can validate suffering without pretending the mechanism is fully known; and how medical categories change when new methods make old boundaries unstable.


The modern answer is not to restore “hysteria” as a diagnosis. It is to understand why the category once seemed necessary, which observations survived, which theories failed, and how its fragments were redistributed into modern neurology, psychiatry, psychology, and dissociation research. That is the real prehistory Charcot provides.


FAQ


Who was Jean-Martin Charcot?


Jean-Martin Charcot was a nineteenth-century French neurologist at the Salpêtrière in Paris. He made major contributions to neurology and became internationally influential for his studies of hysteria, hypnosis, traumatic symptoms, and neurological examination.


What did Charcot believe hysteria was?


His view changed. He initially framed hysteria mainly as a neurological functional disorder associated with hereditary predisposition and a dynamic lesion, then increasingly emphasized trauma, ideas, emotion, suggestibility, and psychological mechanisms. It is more accurate to describe an evolving theory than one fixed doctrine.


Did Charcot believe hysteria was real?


Yes. Charcot treated hysterical symptoms as genuine and involuntary and worked to distinguish them from conscious simulation. This medical legitimization was one of the lasting aspects of his work.


Why did Charcot use hypnosis?


He used hypnosis as an experimental way to reproduce, modify, or relieve phenomena resembling hysterical symptoms and to investigate how suggestion could influence bodily function. His interpretation of hypnosis was contested by the Nancy school.


Did Charcot diagnose hysteria in men?


Yes. His male cases, many connected with accidents or trauma, were historically important because they challenged the idea that hysteria was intrinsically a disorder of women or the reproductive organs.


How did Charcot influence Freud?


Freud studied with Charcot in Paris in 1885–1886. Charcot’s demonstration that severe neurological-like symptoms could occur without a visible structural lesion, and his use of hypnosis and psychological ideas, helped redirect Freud’s attention toward hysteria and psychological explanation. Freud later built a substantially different theory.


Is Charcot’s hysteria the same as functional neurological disorder?


No. There is important historical overlap, especially for functional weakness, movement symptoms, sensory symptoms, and seizure-like episodes, but Charcot’s hysteria was broader and belonged to a different theoretical and diagnostic system. Modern FND requires contemporary assessment and positive clinical evidence.


Is hysteria a diagnosis in DSM-5-TR or ICD-11?


No current diagnosis is simply named hysteria. DSM-5-TR uses categories including Functional Neurological Symptom Disorder (Conversion Disorder) and separate dissociative disorders. ICD-11 includes Dissociative Neurological Symptom Disorder within Dissociative Disorders. Neither system preserves Charcot’s hysteria as one diagnosis.


What does “dynamic lesion” mean in Charcot’s work?


It referred to a functional disturbance capable of producing neurological symptoms without the fixed structural lesion expected in many neurological diseases. It is historically related to later functional concepts, but it is not identical to contemporary neuroscience models.


Related Articles


Hysterical Neurosis: Historical Meaning, Dissociation, and Functional Neurological Symptoms


Breuer and Freud’s Studies on Hysteria: From Hysteria to Psychoanalysis


History of Neurosis: From William Cullen to DSM and ICD


Freud on Hysteria and Neurosis: Conversion, Repression, and Symptom Formation


Neurosis: What It Means Today, Symptoms, History, and Modern Diagnoses


Types of Neurosis: Historical Categories and Their Modern Equivalents


References


American Psychiatric Association. (n.d.). DSM History. https://www.psychiatry.org/psychiatrists/practice/dsm/about-dsm/history-of-the-dsm


Aubignat, M., & Cervellera, P.-A. (2024). Update on the diagnosis and management of functional neurological disorders from Jean-Martin Charcot to 2024. La Revue de Médecine Interne. DOI: 10.1016/j.revmed.2024.11.006. https://pubmed.ncbi.nlm.nih.gov/39613652/


Bell, V., Oakley, D. A., Halligan, P. W., & Deeley, Q. (2011). Dissociation in hysteria and hypnosis: Evidence from cognitive neuroscience. Journal of Neurology, Neurosurgery & Psychiatry, 82(3), 332–339. DOI: 10.1136/jnnp.2009.199158. https://pubmed.ncbi.nlm.nih.gov/20884677/


Bogousslavsky, J. (2011). Sigmund Freud’s evolution from neurology to psychiatry: Evidence from his La Salpêtrière library. Neurology, 77(14), 1391–1394. DOI: 10.1212/WNL.0b013e31823152a1. https://pubmed.ncbi.nlm.nih.gov/21968845/


Bogousslavsky, J. (2020). The mysteries of hysteria: A historical perspective. International Review of Psychiatry, 32(5–6), 437–450. DOI: 10.1080/09540261.2020.1772731. https://pubmed.ncbi.nlm.nih.gov/32500757/


Brigo, F. (2021). Jean-Martin Charcot (1825–1893) and his second thoughts about hysteria. Arquivos de Neuro-Psiquiatria, 79(2), 173–174. DOI: 10.1590/0004-282X-anp-2020-0159. https://pubmed.ncbi.nlm.nih.gov/33759985/


Charcot, J.-M. (1879). Lectures on the Diseases of the Nervous System: Delivered at La Salpêtrière. H. C. Lea. Digitized primary source. https://books.google.com/books?id=eVkSAAAAYAAJ


Espay, A. J., Aybek, S., Carson, A., Edwards, M. J., Goldstein, L. H., Hallett, M., et al. (2018). Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurology, 75(9), 1132–1141. DOI: 10.1001/jamaneurol.2018.1264. https://pubmed.ncbi.nlm.nih.gov/29868890/


Gelfand, T. (2025). Charcot and the psychology of hysteria, with special reference to a never published final case history. Journal of the History of the Neurosciences, 34(2), 263–273. DOI: 10.1080/0964704X.2024.2353000. https://pubmed.ncbi.nlm.nih.gov/39186636/


Goetz, C. G. (2016). Charcot, hysteria, and simulated disorders. Handbook of Clinical Neurology, 139, 11–23. DOI: 10.1016/B978-0-12-801772-2.00002-3. https://pubmed.ncbi.nlm.nih.gov/27719832/


Gomes, M. M., & Engelhardt, E. (2014). A neurological bias in the history of hysteria: From the womb to the nervous system and Charcot. Arquivos de Neuro-Psiquiatria, 72(12), 972–975. DOI: 10.1590/0004-282X20140149. https://pubmed.ncbi.nlm.nih.gov/25517645/


Micale, M. (1994). Charcot and Les Névroses Traumatiques: Historical and scientific reflections. Revue Neurologique, 150(8–9), 498–505. https://pubmed.ncbi.nlm.nih.gov/7754283/


Stone, J., LaFrance, W. C., Jr., Brown, R., Spiegel, D., Levenson, J. L., & Sharpe, M. (2011). Conversion disorder: Current problems and potential solutions for DSM-5. Journal of Psychosomatic Research, 71(6), 369–376. DOI: 10.1016/j.jpsychores.2011.07.005. https://pubmed.ncbi.nlm.nih.gov/22118377/


Walusinski, O., & Bogousslavsky, J. (2020). Charcot, Janet, and French models of psychopathology. European Neurology, 83(3), 333–340. DOI: 10.1159/000508267. https://pubmed.ncbi.nlm.nih.gov/32554964/


World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. https://www.who.int/publications/i/item/9789240077263

 
 
bottom of page